PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis
December 19, 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024 08:00 ET
|
PRISM MarketView
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor
October 21, 2024 12:23 ET
|
PRISM MarketView
PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
September 13, 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
Aclarion Added to PRISM Emerging Medical Devices Index
September 06, 2024 11:27 ET
|
PRISM MarketView
Aclarion Added to PRISM Emerging Medical Devices Index
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
August 20, 2024 09:00 ET
|
PRISM MarketView
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
PRISM MarketView Launches AI Infrastructure and Datacenter Index
August 01, 2024 08:00 ET
|
PRISM MarketView
PRISM MarketView Launches AI Infrastructure and Datacenter Index
PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends
July 30, 2024 11:15 ET
|
PRISM MarketView
PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends
PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results
July 15, 2024 10:16 ET
|
PRISM MarketView
PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
June 17, 2024 14:07 ET
|
PRISM MarketView
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion